The microvessel density in FGF2-overexpressing endometrial cancer xenografts was reduced to control levels by [NSIS6S]-[NSIS]5 with inhibition of FGF2 signaling in tumor blood vessels. This evidence concerns the gene FGF2 and endometrial cancer.